The European NAFLD registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Non-Alcoholic Fatty Liver Disease (NAFLD), a progressive liver disease that is closely associated with obesity, type 2 diabetes, hypertension and dyslipidaemia, represents an increasing global public health challenge. There is significant variability in the disease course: the majority exhibit only fat accumulation in the liver but a significant minority develop a necroinflammatory form of the disease (non-alcoholic steatohepatitis, NASH) that may progress to cirrhosis and hepatocellular carcinoma.

Source: Contemporary Clinical Trials - October 8, 2020 Category: Radiology Authors: Timothy Hardy, Kristy Wonders, Ramy Younes, Guruprasad P. Aithal, Rocio Aller, Michael Allison, Pierre Bedossa, Fay Betsou, Jerome Boursier, M. Julia Brosnan, Alastair Burt, Jeremy Cobbold, Helena Cortez-Pinto, Chris P. Day, Jean-Francois Dufour, Mattias Source Type: research